Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 233-153-9 | CAS number: 10045-95-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Developmental toxicity / teratogenicity
Administrative data
- Endpoint:
- developmental toxicity
- Type of information:
- experimental study
- Adequacy of study:
- supporting study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Scientifically validated test method by ECVAM.
Data source
Reference
- Reference Type:
- publication
- Title:
- Assessment of embryotoxicity of compounds in cosmetics by the embryonic stem cell test
- Author:
- Chen R, Chen J, Cheng S, Qin J, Li W, Zhang L, Jiao H, Yu X, Zhang X, Lahn B T, Xiang A P
- Year:
- 2 010
- Bibliographic source:
- Toxicology Mechanisms and Methods: 20(3): 112-118
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- other: Mouse embryonic stem cell test
- Deviations:
- not specified
- Principles of method if other than guideline:
- Neodymium (III) nitrate was assessed for its embryotoxic potential by the embryonic stem cell test (EST). Three end-points were analyzed. The cytotoxicity of the compound on E14 cells and 3T3 cells (IC50 3T3, IC50 ES) were determined by MTT assay, and the inhibition of cardiomyocyte differentiation of embryonic stem cells (ID50) was determined by microscopic observation on day 10.
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- Neodymium trinitrate
- EC Number:
- 233-153-9
- EC Name:
- Neodymium trinitrate
- Cas Number:
- 10045-95-1
- Molecular formula:
- HNO3.1/3Nd
- IUPAC Name:
- neodymium trinitrate
Constituent 1
Test animals
- Species:
- other: Murine cell line
- Strain:
- other: E14 and Balb/c 3T3
- Details on test animals or test system and environmental conditions:
- Details on cell culture:
Two permanent cell lines were cultured at 37°C and 5% CO2 and routinely passaged three times a week. E14 cells were cultured on mouse embryonic fibroblast feeders (MEF) in a standard ES-cell culture medium containing DMEM supplemented with 10% FCS, 2 mM glutamine, 1% non-essential amino acids, 0.1 mM b-mercaptoethanol, 1000 U/mL leukemia inhibiting factor, 50 U/mL penicillin G, and 50 µg/mL streptomycin. 3T3 fibroblasts were cultured in DMEM containing 10% FCS, 4 mM glutamine, 50 U/mL penicillin G, and 50 µg/mL streptomycin.
Administration / exposure
- Route of administration:
- other: exposure to cells
- Vehicle:
- water
- Details on exposure:
- Cytotoxicity assay:
On day 0, 500 cells in 50 μl routine culture medium without LIF were seeded into each well of a 96-well plate. Culture medium (150 μl) with or without tested compounds were added to each well after 2 h incubation at 37°C and 5% CO2. Each test concentration and positive control was tested in six replicated wells, and seven concentrations were set for each compound in 1:10 dilution. On days 3 and 5, medium was changed with fresh medium containing the respective concentration of tested compounds as on day 0. On day 10, a MTT assay was performed to determine cell viability; 20 μl 5 mg/ml MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) dissolved in PBS was added into each well. After incubation at 37°C and 5% CO2 for 2 h, the medium was removed. Cells were incubated with 130 μl MTT desorbing solution containing 3.49% (v/v) of 20% SDS stock solution and 96.51% (v/v) 2-propanol. Absorbance was measured by a microplate spectrophotometer at 570/630 nm. The cytotoxicity of the tested compounds was determined from the inhibiting concentration of 50% (IC50) obtained through concentration–response curve.
Differentiation assay with ES cells:
750 cells in 20 μl cell culture medium without LIF were seeded as droplet into the lid of a 10-cm Petridish, filled with 10 ml PBS and incubated at 37°C and 5% CO2. After 3 days of hanging drops culture, the cells formed aggregates called embryonic bodies (EBs). The EBs were transferred into a 6-cm bacterial Petri dish and cultured in suspension for 2 days. On day 5, the EBs were placed separately into 24-well plates containing the
appropriated concentration tested compounds, and allowed to attach and outgrow for an additional 5 days. On day 10, the number of wells containing beating myocardial cell areas was counted by using a phase-contrast microscope. Besides solvent control, seven concentrations were set for each compound in 1:10 dilution from 1 mg/ml, except penicillin G from 10 mg/ml and antimony (III) oxide from 10 μg/ml. One 24-well plate containing 24 EBs was used for one test concentration and solvent control. An assay was valid when the solvent control plate had at least 21 wells out of 24 that contained beating myocardial cell areas, and this number were set as 100%. The inhibition of differentiation (ID50) was calculated from the concentration–response curve. - Analytical verification of doses or concentrations:
- no
- Details on mating procedure:
- Not applicable
- Duration of treatment / exposure:
- 10 days
- Frequency of treatment:
- On days 3 and 5, medium was changed with fresh medium containing the respective concentration of tested compounds as on day 0.
- Duration of test:
- 10 days
- No. of animals per sex per dose:
- Not applicable
- Control animals:
- other: not applicable
- Details on study design:
- seven concentrations were set in 1:10 dilution
Examinations
- Maternal examinations:
- Not applicable
- Ovaries and uterine content:
- Not applicable
- Fetal examinations:
- Not applicable
- Statistics:
- The statistical analysis was performed using SPSS version 13.0. Data were expressed as mean ± SEM. Each data point represented three independent experiments. Criterion for significance was p<0.05.
Results and discussion
Results: maternal animals
Maternal developmental toxicity
- Details on maternal toxic effects:
- Details on maternal toxic effects:
Not examined
Results (fetuses)
- Details on embryotoxic / teratogenic effects:
- Embryotoxic / teratogenic effects:yes. Remark: weak
Details on embryotoxic / teratogenic effects:
See field 'Any other information on results incl. tables'.
Fetal abnormalities
- Abnormalities:
- not specified
Overall developmental toxicity
- Developmental effects observed:
- not specified
Any other information on results incl. tables
Positive and negative control results:
5 -fluorouracil and penicillin G were respectively classified as strongly and non-embryotoxic.
Neodymium (III) nitrate hexahydrate:
In the MTT assay, neodymium (III) nitrate hexahydrate showed weak cytotoxicity on 3T3 cells and ES cells (IC50 3T3 541.4 µg/mL, IC50 ES 374.8 µg/mL), and ES cells were more susceptible to the cytotoxic effects of neodymium (III) nitrate hexahydrate than 3T3 cells. The differentiation of ES cells into contracting cardiomyocytes (ID50 188.7 µg/mL) was a little more sensitive than the MTT assay of 3T3 cells. Neodymium (III) nitrate hexahydrate was concluded to possess weak embryotoxicity.
Applicant's summary and conclusion
- Conclusions:
- Neodymium (III) nitrate hexahydrate was concluded to possess weak embryotoxicity in an in vitro test. However this study is not adequate to support hazard classification. In addition, no NOAEL or other dose-response information required for risk assessment purposes is provided by a such a test
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.